Optimisation, validation and application of a capillary electrophoretic method for the determination of zafirlukast in pharmaceutical formulations

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 1, 2007, Pages 16-22

  Süslü, Incilay ^a   Demircan, Şeyda ^a   Altinöz, Sacide ^a   Kir, Sedef ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Capillary zone electrophoresis; Optimisation; Tablet analysis; Validation; Zafirlukast

Indexed keywords

MELOXICAM; ZAFIRLUKAST;

ARTICLE; CALIBRATION; CAPILLARY ELECTROPHORESIS; DRUG DETERMINATION; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRODYNAMICS; PH MEASUREMENT; PRIORITY JOURNAL;

BORATES; BUFFERS; CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CAPILLARY; HYDROGEN-ION CONCENTRATION; LEUKOTRIENE ANTAGONISTS; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS; TEMPERATURE; THIAZINES; THIAZOLES; TIME FACTORS; TOSYL COMPOUNDS;

EID: 34047248373     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.01.008     Document Type: Article

References (32)

1. Lipworth B.J. Lancet 353 (1999) 57-62
2. Balzano G., Fuschillo S., and Gaudiosi C. Allergy 57 (2002) 16-19
3. Adkins J.C., and Brogden R.N. Drugs 55 (1998) 121-144
4. Mc Millan R.M. Pediatr. Respir. Rev. 2 (2001) 238-244
5. Phipatanakul W., Eggleston P.A., Conover-Walker M.K., Kesavanathan J., Sweitzer D., and Wood R. J. Allergy Clin. Immunol. 105 (2000) 704-710
6. Calhoun W.J. Am. J. Respir. Crit. Care Med. 157 (1998) 238-245
7. Spector S.L. Drugs 52 (1996) 36-46
8. Coreno A., Skowronski M., Kotaru C., and McFadden E.R. J. Allergy Clin. Immunol. 106 (2000) 500-506
9. Conway S.P., Etherington C., Peckham D.G., and Whitehead A.J. Cystic Fibrosis 2 (2003) 25-28
10. Huang C.J., Wang C.H., Liu W.T., Yang M.C., Lin H.C., Yu C.T., Shiao C.J., Tan C.C., Yang C.K., and Kuo H.P. Chang Gung Med. J. 26 (2003) 554-560
11. Kemp J.P. J. Am. Respir. Med. 2 (2003) 139-156
12. Ficarra R., Ficarra P., Tommasini S., Melardi S., Calabro M.L., Furlanetto S., and Semreen M. J. Pharm. Biomed. Anal. 23 (2000) 169-174
13. Radhakrishna T., Satyanarayana J., and Satyanarayana A. J. Pharm. Biomed. Anal. 30 (2002) 695-703
14. Bui K.H., Coleen M.K., Connie T.A., and Bruce K.B. J. Chromatogr. B 696 (1997) 131-136
15. Süslü I., and Alti{dotless}nöz S. JAOAC Intern. 89 (2006) 1557-1564
16. Süslü I., and Alti{dotless}nöz S. J. Pharm. Biomed. Anal. 39 (2005) 535-542
17. Süslü I., and Alti{dotless}nöz S. Anal. Lett. 38 (2005) 1625-1639
18. ICH Harmonised Tripartite Guideline, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, "Validation of Analytical Procedure: Methodology" (1996)
19. Mayer B.X. J. Chromatogr. A 907 (2001) 21-37
20. Pereira E.A., Micke G.A., and Tavares F.M. J. Chromatogr. A 1091 (2005) 169-176
21. Taverniers I., Bockstaele E.V., and Loose M.D. Trends Anal. Chem. 23 (2004) 535-552
22. Hibbert B. Accred. Qual. Asur. 4 (1999) 352-356
23. Causon R. J. Chromatogr. B 689 (1997) 175-180
24. Gika H.G., Samanidou V.F., and Papadoyannis I.N. J. Chromatogr. B 814 (2005) 163-172
25. Braggio S., Barnaby R.J., Grossi P., and Cugola M. J. Pharm. Biomed. Anal. 14 (1996) 375-388
26. Green J.M. Anal. Chem. 68 (1996) 305A-309A
27. Ghoneim M.M., and Beltagi A.M. Talanta 60 (2003) 911-921
28. Radhakrishna T., Rao D.S., and Reddy G.O. J. Pharm. Biomed. Anal. 29 (2002) 593-607
29. Ghoneim M.M., El-Baradie K.Y., and Tawfik A. J. Pharm. Biomed. Anal. 33 (2003) 673-685
30. Altria K.D., and Fabre H. LC-GC Europe (2001) 302-308
31. Pospisilova M., Polasek M., and Jokl V. J. Pharm. Biomed. Anal. 24 (2001) 421-428
32. Hamam E. J. Pharm. Biomed. Anal. 30 (2002) 651-659